Parenteral Nutrition-Induced Liver Function Complications: Incidence, Risk Factors, and Prognosis
Journal of Clinical Medicine · 13.02.2025 · 14 (4) · 1220
DOI: 10.3390/jcm14041220 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 13.02.2025. Verfasst von Jae Woo Park und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Gastroenterology and Hepatology, School of Medicine, Soonchunhyang University, Bucheon 14584, Republic of Korea. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Soonchunhyang University, Soonchunhyang University Research Fund.
Abstract (Originalsprache)
Background/Objectives: Parenteral Nutrition-Associated Liver Disease (PNALD) is a significant complication in patients undergoing parenteral nutrition (PN). This study aims to explore the incidence, risk factors, and outcomes associated with PNALD, including abnormal liver function tests, in patients receiving parenteral nutrition, even in short-term PN recipients.
Methods
A retrospective analysis of 500 patients receiving PN for at least 3 days at a tertiary medical center was conducted. Liver enzyme levels were monitored for 28 days, and PN duration, comorbidities, and metabolic factors were analyzed to identify independent risk factors of abnormal liver function tests and PNALD.
Results
This study reported a 24.4% incidence of abnormal liver function tests and an 8.2% incidence of PNALD. Risk factors for abnormal liver function tests included liver disease (OR 2.064, 95% CI 1.224–3.479), infection (OR 1.654, 95% CI 1.075–2.546), PN duration (OR 1.035, 95% CI 1.014–1.056), and PN calories (OR 1.001, 95% CI 1.000–1.002). Significant PNALD risk factors comprised liver disease (OR 3.623, 95% CI 1.670–7.858), lung disease (OR 3.648, 95% CI 1.615–8.240), recent surgery (OR 3.719, 95% CI 1.645–8.407), PN duration (OR 1.041, 95% CI 1.016–1.068), total cholesterol (OR 1.005, 95% CI 1.000–1.010), and HDL-cholesterol (OR 1.012, 95% CI 1.001–1.023). The majority of PNALD cases (85.3%) showed improvement with PN modification or cessation.
Conclusions
This study underscores that abnormal liver function tests and PNALD risks can emerge with short-term PN use. Identifying and addressing patient-specific risk factors is vital for predicting and preventing PNALD onset.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Gastroenterology and Hepatology, School of Medicine, Soonchunhyang University, Bucheon 14584, Republic of Korea.
ORCID-Profile: Sang Gyune Kim, Young Seok Kim, Jeong-Ju Yoo
Förderung
- Soonchunhyang University
- Soonchunhyang University Research Fund
Zitieren
APA
Park, J. W., Maeng, S. A., Kim, S. G., Kim, Y. S., & Yoo, J. J. (2025). Parenteral Nutrition-Induced Liver Function Complications: Incidence, Risk Factors, and Prognosis. Journal of Clinical Medicine, 14(4), 1220. https://doi.org/10.3390/jcm14041220
Vancouver
Park JW, Maeng SA, Kim SG, Kim YS, Yoo JJ. Parenteral Nutrition-Induced Liver Function Complications: Incidence, Risk Factors, and Prognosis. Journal of Clinical Medicine. 2025;14(4):1220. doi:10.3390/jcm14041220
BibTeX
@article{Park2025,
author = {Park, Jae Woo and Maeng, Sun Ah and Kim, Sang Gyune and Kim, Young Seok and Yoo, Jeong-Ju},
title = {Parenteral Nutrition-Induced Liver Function Complications: Incidence, Risk Factors, and Prognosis},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {4},
pages = {1220},
doi = {10.3390/jcm14041220}
}
EUVIMED